Tetraarsenic hexoxide induces Beclin-1-induced autophagic cell death as well as caspase-dependent apoptosis in U937 human leukemic cells

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Han, Min Ho ^a   Lee, Won Sup ^b   Lu, Jing Nan ^b   Yun, Jeong Won ^b   Kim, Gonsup ^c   Jung, Jin Myung ^b   Kim, Gi Young ^d   Lee, Su Jae ^e   Kim, Wun Jae ^f   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Jeju National University   (South Korea)

^e Hanyang University   (South Korea)

^f Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ARSENIC DERIVATIVE; BECLIN 1; CASPASE; PROTEIN BCL 2; TETRAARSENIC HEXOXIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CELL DEATH; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; KOREAN MEDICINE; LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 81555198039     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/201414     Document Type: Article

References (30)

1. Shen Z. X., Chen G. Q., Ni J. H., Li X. S., Xiong S. M., Qiu Q. Y., Zhu J., Tang W., Sun G. L., Yang K. Q., Chen Y., Zhou L., Fang Z. W., Wang Y. T., Ma J., Zhang P., Zhang T. D., Chen S. J., Chen Z., Wang Z. Y., Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 1997 89 9 3354 3360
2. Niu C., Yan H., Yu T., Sun H. P., Liu J. X., Xiu-Song L., Wu W., Zhang F. Q., Chen Y., Zhou L., Li J. M., Zeng X. Y., Yang R. R. O., Yuan M. M., Ren M. Y., Gu F. Y., Cao Q., Gu B. W., Su X. Y., Chen G. Q., Xiong S. M., Zhang T. D., Waxman S., Wang Z. Y., Chen Z., Hu J., Shen Z. X., Chen S. J., Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients Blood 1999 94 10 3315 3324 (Pubitemid 29536124)
3. Munshi N. C., Tricot G., Desikan R., Badros A., Zangari M., Toor A., Morris C., Anaissie E., Barlogie B., Clinical activity of arsenic trioxide for the treatment of multiple myeloma Leukemia 2002 16 9 1835 1837
4. Lin Y. C., Li D. R., Lin W., Relationship between radiotherapy enhancing effect of arsenic trioxide and the proliferation and apoptosis of related protein in nasopharyngeal carcinoma patients Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 2007 27 8 704 707
5. Walker P. R., Sikorska M., New aspects of the mechanism of DNA fragmentation in apoptosis Biochemistry and Cell Biology 1997 75 4 287 299 (Pubitemid 127733180)
6. Schwartz L. M., Smith S. W., Jones M. E. E., Osborne B. A., Do all programmed cell deaths occur via apoptosis? Proceedings of the National Academy of Sciences of the United States of America 1993 90 3 980 984 (Pubitemid 23053934)
7. Chen G. Q., Zhu J., Shi X. G., Ni J. H., Zhong H. J., Si G. Y., Jin X. L., Tang W., Li X. S., Xong S. M., Shen Z. X., Sun G. L., Ma J., Zhang P., Zhang T. D., Gazin C., Naoe T., Chen S. J., Wang Z. Y., Chen Z., In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML- RAR /PML proteins Blood 1996 88 3 1052 1061 (Pubitemid 26333331)
8. Zhu X. H., Shen Y. L., Jing Y. K., Cai X., Jia P. M., Huang Y., Tang W., Shi G. Y., Sun Y. P., Dai J., Wang Z. Y., Chen S. J., Zhang T. D., Waxman S., Chen Z., Chen G. Q., Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations Journal of the National Cancer Institute 1999 91 9 772 778 (Pubitemid 29239056)
9. Look A. T., Arsenic and apoptosis in the treatment of acute promyelocytic leukemia Journal of the National Cancer Institute 1998 90 2 86 88
10. Chang H. S., Bae S. M., Kim Y. W., Kwak S. Y., Min H. J., Bae I. J., Lee Y. J., Shin J. C., Kim C. K., Ahn W. S., Comparison of diarsenic oxide and tetraarsenic oxide on anticancer effects: relation to the apoptosis molecular pathway International Journal of Oncology 2007 30 5 1129 1135
11. Cui Z. G., Hong N. Y., Guan J., AMP antagonizes ERK-dependent antiapoptotic action of insulin Biochemistry and Molecular Biology Reports 1997 44 3 205 210
12. Cho S. Y., Lee J. H., Bae H. D., Jeong E. M., Jang G. Y., Kim C. W., Shin D. M., Jeon J. H., Kim I. G., Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax Experimental and Molecular Medicine 2010 42 9 639 650
13. Goussetis D. J., Altman J. K., Glaser H., McNeer J. L., Tallman M. S., Platanias L. C., Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide Journal of Biological Chemistry 2010 285 39 29989 29997
14. Park I. C., Park M. J., Woo S. H., Lee H. C., An S., Gwak H. S., Lee S. H., Hong S. I., Bae I. J., Seo K. M., Rhee C. H., Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway International Journal of Oncology 2003 23 4 943 948
15. Dai J., Weinberg R. S., Waxman S., Jing Y., Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system Blood 1999 93 1 268 277 (Pubitemid 29019412)
16. Ai Z., Lu W., Qin X., Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2 Biochemical and Biophysical Research Communications 2006 348 3 1075 1081 (Pubitemid 44233524)
17. Nutt L. K., Gogvadze V., Uthaisang W., Mirnikjoo B., McConkey D. J., Orrenius S., Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis Cancer Biology and Therapy 2005 4 4 459 467 (Pubitemid 41351266)
18. Kang Y. H., Yi M. J., Kim M. J., Park M. T., Bae S., Kang C. M., Cho C. K., Park I. C., Park M. J., Rhee C. H., Hong S. I., Chung H. Y., Lee Y. S., Lee S. J., Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria Cancer Research 2004 64 24 8960 8967 (Pubitemid 39665504)
19. Kanzawa T., Kondo Y., Ito H., Kondo S., Germano I., Induction of autophagic cell death in malignant glioma cells by arsenic trioxide Cancer Research 2003 63 9 2103 2108 (Pubitemid 36538613)
20. Sanchez Y., Calle C., de Blas E., Aller P., Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases Chemico-Biological Interactions 2009 182 1 37 44
21. Qian W., Liu J., Jin J., Ni W., Xu W., Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1 Leukemia Research 2007 31 3 329 339 (Pubitemid 46073178)
22. Borutaite V., Mitochondria as decision-makers in cell death Environmental and Molecular Mutagenesis 2010 51 5 406 416
23. Chakraborty J., Banerjee S., Ray P., Hossain D. M. S., Bhattacharyya S., Adhikary A., Chattopadhyay S., Das T., Sa G., Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells Journal of Biological Chemistry 2010 285 43 33104 33112
24. Smith D. M., Patel S., Raffoul F., Haller E., Mills G. B., Nanjundan M., Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells Cell Death and Differentiation 2010 17 12 1867 1881
25. Zhuang W., Qin Z., Liang Z., The role of autophagy in sensitizing malignant glioma cells to radiation therapy Acta Biochimica et Biophysica Sinica 2009 41 5 341 351
26. Kanzawa T., Germano I. M., Komata T., Ito H., Kondo Y., Kondo S., Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells Cell Death and Differentiation 2004 11 4 448 457 (Pubitemid 38489422)
27. Pattingre S., Tassa A., Qu X., Garuti R., Xiao H. L., Mizushima N., Packer M., Schneider M. D., Levine B., Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 2005 122 6 927 939 (Pubitemid 41345209)
28. Ciechomska I. A., Goemans C. G., Tolkovsky A. M., Why doesn't Beclin 1, a BH3-only protein, suppress the anti-apoptotic function of Bcl-2? Autophagy 2009 5 6 881 882
29. Ciechomska I. A., Goemans G. C., Skepper J. N., Tolkovsky A. M., Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function Oncogene 2009 28 21 2128 2141
30. Yu L., Wan F., Dutta S., Welsh S., Liu Z., Freundt E., Baehrecke E. H., Lenardo M., Autophagic programmed cell death by selective catalase degradation Proceedings of the National Academy of Sciences of the United States of America 2006 103 13 4952 4957